Effects of famotidine use during pregnancy: an observational cohort study
This observational cohort study revealed that exposure to famotidine during the first trimester of pregnancy was not associated with an increased risk of congenital malformations in infants. Although a higher rate of preterm delivery was detected in famotidine users when compared with controls, this could be attributed to confounding factors, such as complications.
Authors
- Atsuko Murashima (ORCID: https://orcid.org/0000-0002-0569-7172)
- Naho Yakuwa (ORCID: https://orcid.org/0000-0002-3869-6221)
- Mikako Goto (ORCID: https://orcid.org/0000-0001-5569-9275)
- Ayako Furugen (ORCID: https://orcid.org/0000-0002-2081-5827)
- Masaki Kobayashi (ORCID: https://orcid.org/0000-0003-3762-2391)
- Masahiro Hayashi (ORCID: https://orcid.org/0000-0002-1674-4093)
- Mitsuru Sugawara (ORCID: https://orcid.org/0000-0001-5350-2950)
- Yoh Takekuma (ORCID: https://orcid.org/0000-0002-4325-0785)
- Ayako Nishimura (ORCID: https://orcid.org/0000-0002-0309-4845)
Institutions
- Hokkaido University (JP)
- Hokkaido Pharmaceutical University (JP)
- Hokuyukai Neurology Hospital (JP)
- National Center For Child Health and Development (JP)
- Hokkaido University Hospital (JP)
- Toranomon Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1186/s40780-024-00393-3
- Citations
- 3
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 3.33